Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentanyl buccal tablets titration in breakthrough cancer pain
2008-001841-24Phase 4Completed
- Sponsor
- Cephalon, Inc.
- Start
- May 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of fentanyl in breakthrough cancer pain (BTcP) (2 arms), sponsored by Cephalon, Inc. Primary endpoint: Number of patients reaching an effective fentanyl buccal tablet dose. Started May 2008; status: completed.
02
Drugs
fentanyl
03
Conditions
breakthrough cancer pain (BTcP)
Beyond the preview
Go deeper on 2008-001841-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001841-24.